Harald Kühnel

Dr. Harald Kühnel

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2010 in Aging Cell
Verified
Journal Article
Open access
PDF file
MHMatthias Hackl
Matthias Hackl
SBStefan Brunner
Stefan Brunner
KFKlaus Fortschegger
Klaus Fortschegger
CSCarina Schreiner
Carina Schreiner
LMLucia Micutkova
Lucia Micutkova
JGJohannes Grillari
Johannes Grillari
Summary: Aging is a multifactorial process where deterioration of body functions is driven by stochastic damage while counteracted by distinct genetically encoded repair systems. To better understand the genetic component of aging, many studies have addressed the gene and protein expression profiles of various aging model systems engaging different organisms from yeast to human. The recently identified small non‐coding miRNAs are potent post‐transcriptional regulators that can modify the expression of up to several hundred target genes per single miRNA, similar to transcription factors. Increasing evidence shows that miRNAs contribute to the regulation of most if not all important physiological processes, including aging. However, so far the contribution of miRNAs to age‐related and senescence‐related changes in gene expression remains elusive. To address this question, we have selected four replicative cell aging models including endothelial cells, replicated CD8+ T cells, renal proximal tubular epithelial cells, and skin fibroblasts. Further included were three organismal aging models including foreskin, mesenchymal stem cells, and CD8+ T cell populations from old and young donors. Using locked nucleic acid‐based miRNA microarrays, we identified four commonly regulated miRNAs, miR‐17 down‐regulated in all seven; miR‐19b and miR‐20a, down‐regulated in six models; and miR‐106a down‐regulated in five models. Decrease in these miRNAs correlated with increased transcript levels of some established target genes, especially the cdk inhibitor p21/CDKN1A. These results establish miRNAs as novel markers of cell aging in humans.

15 March 2013 in Aging Cell
Verified
Journal Article
Open access
PDF file
HDHanna Dellago
Hanna Dellago
BPBarbara Preschitz‐Kammerhofer
Barbara Preschitz‐Kammerhofer
LTLucia Terlecki‐Zaniewicz
Lucia Terlecki‐Zaniewicz
CSCarina Schreiner
Carina Schreiner
KFKlaus Fortschegger
Klaus Fortschegger
MWMatthias Wieser
Matthias Wieser
Summary: Cellular senescence of normal human cells has by now far exceeded its initial role as a model system for aging research. Many reports show the accumulation of senescent cells in vivo, their effect on their microenvironment and its double‐edged role as tumour suppressor and promoter. Importantly, removal of senescent cells delays the onset of age‐associated diseases in mouse model systems. To characterize the role of miRNAs in cellular senescence of endothelial cells, we performed miRNA arrays from HUVECs of five different donors. Twelve miRNAs, comprising hsa‐miR‐23a, hsa‐miR‐23b, hsa‐miR‐24, hsa‐miR‐27a, hsa‐miR‐29a, hsa‐miR‐31, hsa‐miR‐100, hsa‐miR‐193a, hsa‐miR‐221, hsa‐miR‐222 and hsa‐let‐7i are consistently up‐regulated in replicatively senescent cells. Surprisingly, also miR‐21 was found up‐regulated by replicative and stress‐induced senescence, despite being described as oncogenic. Transfection of early passage endothelial cells with miR‐21 resulted in lower angiogenesis, and less cell proliferation mirrored by up‐regulation of p21CIP1 and down‐regulation of CDK2. These two cell‐cycle regulators are indirectly regulated by miR‐21 via its validated direct targets NFIB (Nuclear factor 1 B‐type), a transcriptional inhibitor of p21CIP1, and CDC25A, which regulates CDK2 activity by dephosphorylation. Knock‐down of either NFIB or CDC25A shows a phenocopy of over‐expressing miR‐21 in regard to cell‐cycle arrest. Finally, miR‐21 over‐epxression reduces the replicative lifespan, while stable knock‐down by sponges extends the replicative lifespan of endothelial cells. Therefore, we propose that miR‐21 is the first miRNA that upon its knock‐down extends the replicative lifespan of normal human cells.

1 September 2015 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MTMichael Thiele
Michael Thiele
RKRandolf J. Kerschbaumer
Randolf J. Kerschbaumer
FTFrederick W. K. Tam
Frederick W. K. Tam
DVDirk Völkel
Dirk Völkel
PDPatrice Douillard
Patrice Douillard
FSFriedrich Scheiflinger
Friedrich Scheiflinger
Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine and counterregulator of glucocorticoids, is a potential therapeutic target. MIF is markedly different from other cytokines because it is constitutively expressed, stored in the cytoplasm, and present in the circulation of healthy subjects. Thus, the concept of targeting MIF for therapeutic intervention is challenging because of the need to neutralize a ubiquitous protein. In this article, we report that MIF occurs in two redox-dependent conformational isoforms. We show that one of the two isoforms of MIF, that is, oxidized MIF (oxMIF), is specifically recognized by three mAbs directed against MIF. Surprisingly, oxMIF is selectively expressed in the plasma and on the cell surface of immune cells of patients with different inflammatory diseases. In patients with acute infections or chronic inflammation, oxMIF expression correlated with inflammatory flare-ups. In addition, anti-oxMIF mAbs alleviated disease severity in mouse models of acute and chronic enterocolitis and improved, in synergy with glucocorticoids, renal function in a rat model of crescentic glomerulonephritis. We conclude that oxMIF represents the disease-related isoform of MIF; oxMIF is therefore a new diagnostic marker for inflammation and a relevant target for anti-inflammatory therapy.

1 October 2012 in Journal of Virology
Verified
Journal Article
Closed access
RRRita Reynoso
Rita Reynoso
MWMatthias Wieser
Matthias Wieser
DODiego Ojeda
Diego Ojeda
MBMaximilian Bönisch
Maximilian Bönisch
Harald KühnelHarald Kühnel
Harald Kühnel
JQJorge Quarleri
Jorge Quarleri
Monocyte-derived macrophages (MDM) are widely distributed in all tissues and organs, including the central nervous system, where they represent the main part of HIV-infected cells. In contrast to activated CD4+T lymphocytes, MDM are resistant to cytopathic effects and survive HIV infection for a long period of time. The molecular mechanisms of how HIV is able to persist in macrophages are not fully elucidated yet. In this context, we have studied the effect ofin vitroHIV-1 infection on telomerase activity (TA), telomere length, and DNA damage. Infection resulted in a significant induction of TA. This increase was directly proportional to the efficacy of HIV infection and was found in both nuclear and cytoplasmic extracts, while neither UV light-inactivated HIV nor exogenous addition of the viral protein Tat or gp120 affected TA. Furthermore, TA was not modified during monocyte-macrophage differentiation, MDM activation, or infection with vaccinia virus. HIV infection did not affect telomere length. However, HIV-infected MDM showed less DNA damage after oxidative stress than noninfected MDM, and this resistance was also increased by overexpressing telomerase alone. Taken together, our results suggest that HIV induces TA in MDM and that this induction might contribute to cellular protection against oxidative stress, which could be considered a viral strategy to make macrophages better suited as longer-lived, more resistant viral reservoirs. In the light of the clinical development of telomerase inhibitors as anticancer therapeutics, inhibition of TA in HIV-infected macrophages might also represent a novel therapeutic target against viral reservoirs.

Verified
Journal Article
Open access
PDF file
MIMonika Imb
Monika Imb
ZVZsolt Véghelyi
Zsolt Véghelyi
MMMichael Maurer
Michael Maurer
Harald KühnelHarald Kühnel
Harald Kühnel
Senolytic and senomorphic therapies have gained more and more attention in the last decade. This kind of therapy is based on the killing of cellular senescent cells without harming the “normal” cells. Aging is not a disease. Clinical studies on healthy people will be difficult to conduct. Therefore, one possibility is to draw on the large repertoire of medicinal plants and use their senolytic properties to provide mild anti-aging therapies. Chamomile, goldenrod, reishi, and green tea were tested for their ability to trigger senolysis. Quercetin was used as control substance. Cellular senescence was induced with 25 µM etoposide in human dermal fibroblasts and established for at least 14 days. The plant extracts were tested for their antioxidant potential (DPPH assay) and their polyphenol content. Senolysis was determined by presto blue assay of young and etoposide-induced senescent cells, and SA-β-Gal assays were also performed. The senomorphic properties of the plants were investigated using IL-6 ELISA and qPCR. It turned out that chamomile triggers a kind of cytokine storm and causes the cytokine values in the ELISA and in the qPCR to rise extremely, and other senescence-associated phenotype (SASP) markers were also elevated. Goldenrod and quercetin tend to have a senolytic and senomorphic effect, respectively. Regarding the senolytic and senomorphic properties of herbs, we found that all tested herbs can have a senolytic effect, and a senomorphic effect of quercetin has also been discovered. With regard to the effect of chamomile, however, we can say that seemingly harmless tea products may have harmful effects, especially in combination with chemotherapy, at least in cell culture experiments. Nevertheless, inflammation is a double-bladed mechanism with positive effects, for example, in healing, but also known negative effects.

19 May 2012 in Chinese Journal of Integrative Medicine
Verified
Journal Article
Closed access
PDF file
AAAdiljan Ablimit
Adiljan Ablimit
Harald KühnelHarald Kühnel
Harald Kühnel
ASAlois Strasser
Alois Strasser
HUHalmurat Upur
Halmurat Upur